Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor Company (005380) – Decision to Acquire Treasury Shares via Open Market for Shareholder Value Enhancement (Approx. KRW 400.69B)

Posted on January 29, 2026July 23, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor Company (005380) – Decision to Acquire Treasury Shares via Open Market for Shareholder Value Enhancement (Approx. KRW 400.69B)

Fact Source: Financial Supervisory Service DART / 2026-01-29

Disclosure Type: Decision on Acquisition of Treasury Stock

💡 3-Second Summary

Hyundai Motor Company resolved to acquire 744,870 common shares and 125,054 preferred shares via the open market, totaling approximately KRW 400.69 billion, to enhance shareholder value in accordance with its Value-up Program and shareholder return policy.

📊 1. [Key Disclosure Details & Financial Figures Summary]

  • Scheduled Shares to Acquire:
    • Common Stock: 744,870 shares
    • Other (Preferred) Stock: 125,054 shares (48,141 1st preferred, 72,113 2nd preferred, and 4,800 3rd preferred shares)
  • Estimated Acquisition Amount:
    • Common Stock: KRW 366,848,475,000 (Approx. KRW 366.85B)
    • Other (Preferred) Stock: KRW 33,843,935,500 (Approx. KRW 33.84B)
    • Total Amount: KRW 400,692,410,500 (Approx. KRW 400.69B)
  • Expected Acquisition Period: January 30, 2026 – April 27, 2026
  • Purpose of Acquisition: Enhancing shareholder value (fulfilling Value-up Program targets and mid-to-long term 1% treasury stock cancellation policy)
  • Method of Acquisition: Open market purchase
  • Entrusted Brokerage: Hyundai Motor Securities
  • Daily Purchase Order Limit: 944,571 common shares; 88,628 1st preferred shares; 94,559 2nd preferred shares; 12,921 3rd preferred shares
  • Board Resolution Date: January 29, 2026 (All 7 independent directors attended)

📈 2. [Expert Insight: What This Disclosure Means for Investors]

This filing details the open-market purchase of treasury shares executed as part of Hyundai Motor Company’s Value-up Program and mid-to-long-term shareholder return commitment.

The company plans to buy back approximately KRW 400.69 billion worth of common and preferred shares. Specific details regarding the utilization of these acquired shares (such as cancellation) will be disclosed following future Board resolutions.

📝 Editor’s Comment (by K-STOCK Editor)

Hyundai Motor Company’s treasury stock acquisition filing reflects its ongoing commitment to shareholder return policies through direct open-market repurchases.

Investors should track the open-market execution timeline through April 27, 2026, alongside subsequent disclosures regarding the Board’s decision on share utilization.

📢 Disclaimer & Source Notice

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.

Contact Us: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Hyundai Motor Company (005380) – Status & Plans for Fair Trade Compliance Program (CP) and Appointment of Compliance Manager
Next Post: [Disclosure] Hyundai Motor Company (005380) – Decision on FY2025 Year-End Cash Dividend (KRW 2,500 per Common Share, Total Approx. KRW 660.16B)

Related Posts

[Disclosure] Jeju Semiconductor (080220) – Decision on Issuance of Convertible Bonds (8th Series) / 2025-02-20 Semiconductors
[Disclosure] Celltrion (068270) – CHMP Recommendation for Marketing Authorization for CT-P41 (Prolia & Xgeva Biosimilar) / 2024-12-16 Disclosures
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-07-22 Disclosures
[Disclosure] Hyundai Motor (005380) – Voluntary Filing on Execution Status of Corporate Value-Up Plan (2025) Disclosures
[Disclosure] ALTEOGEN (196170) – Results of General Shareholders Meeting / 2025-03-31 Disclosures
[Disclosure] SK Hynix (000660) – Matters Related to Fair Disclosure Obligations / 2024-11-27 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme